Identification and susceptibility testing of &ITCandida spp&IT. directly from yeast-positive blood cultures with Vitek 2

被引:1
作者
Fernanda Gonzalez-Lara, Maria [1 ]
Torres-Gonzalez, Pedro [1 ]
Rangel-Cordero, Andrea [1 ]
Sifuentes-Osornio, Jose [2 ]
Ponce-de-Leon, Alfredo [1 ]
Martinez-Gamboa, Areli [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Lab Clin Microbiol, Ave Vasco de Quiroga 15, Mexico City 14080, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Ave Vasco de Quiroga 15, Mexico City 14080, DF, Mexico
关键词
Candida spp; Vitek; 2; Identification; Antifungal susceptibility test; RAPID IDENTIFICATION; CLINICAL BREAKPOINTS; FLUCONAZOLE; SYSTEM; VORICONAZOLE; BACTEC-9240; CANDIDEMIA; BOTTLES; PANEL;
D O I
10.1016/j.diagmicrobio.2017.07.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Culture-based identification and antifungal susceptibility take 48-72 hours after positivity. We analyzed the performance of Vitek2 directly from 40 yeast-positive blood-cultures; agreement of 100% was observed for the tested antifungals; identification showed the same species in 31/40. The method reduces time (13 to 18 h) for preliminary results. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:202 / 204
页数:3
相关论文
共 27 条
  • [1] [Anonymous], 0690435ES1 BIOMERIEU
  • [2] Evaluation of Caspofungin Susceptibility Testing by the New Vitek 2 AST-YS06 Yeast Card Using a Unique Collection of FKS Wild-Type and Hot Spot Mutant Isolates, Including the Five Most Common Candida Species
    Astvad, Karen M.
    Perlin, David S.
    Johansen, Helle K.
    Jensen, Rasmus H.
    Arendrup, Maiken C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 177 - 182
  • [3] Avolio M, 2009, NEW MICROBIOL, V32, P179
  • [4] Bruins M, 2004, J CLIN MICROBIOL, V42
  • [5] CLSI, 2012, REF METH BROTH MICR
  • [6] Time to positive culture and identification for Candida blood stream infections
    Fernandez, Julianna
    Erstad, Brian L.
    Petty, Wanda
    Nix, David E.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (04) : 402 - 407
  • [7] Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
    Garey, Kevin W.
    Rege, Milind
    Pai, Manjunath P.
    Mingo, Dana E.
    Suda, Katie J.
    Turpin, Robin S.
    Bearden, David T.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) : 25 - 31
  • [8] Evaluation of a new extraction protocol for yeast identification by mass spectrometry
    Gouriet, Frederique
    Ghiab, Farida
    Couderc, Carine
    Bittar, Fadi
    Dupont, Herve Tissot
    Flaudrops, Christophe
    Casalta, Jean-Paul
    Sambe-Ba, Bissoume
    Fall, Becaye
    Raoult, Didier
    Fenollar, Florence
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2016, 129 : 61 - 65
  • [9] Rapid Antifungal Susceptibility Determination for Yeast Isolates by Use of Etest Performed Directly on Blood Samples from Patients with Fungemia
    Guinea, Jesus
    Recio, Sandra
    Escribano, Pilar
    Torres-Narbona, Marta
    Pelaez, Teresa
    Sanchez-Carrillo, Carlos
    Rodriguez-Creixems, Marta
    Bouza, Emilio
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (06) : 2205 - 2212
  • [10] Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection
    Horvath, LL
    George, BJ
    Murray, CK
    Harrison, LS
    Hospenthal, DR
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) : 115 - 118